Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP446481.RAl891B3Di4zrBVC_rBSW5lOE5KMcm348CTsS_aAHoZSY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP446481.RAl891B3Di4zrBVC_rBSW5lOE5KMcm348CTsS_aAHoZSY130_assertion type Assertion NP446481.RAl891B3Di4zrBVC_rBSW5lOE5KMcm348CTsS_aAHoZSY130_head.
- NP446481.RAl891B3Di4zrBVC_rBSW5lOE5KMcm348CTsS_aAHoZSY130_assertion description "[We digested the DNA samples with various restriction endonucleases, conducted standard Southern blotting, and searched for restriction fragment length polymorphisms for the following candidate genes (probe names in parentheses): multiple endocrine neoplasia (MEN) type 1 (pMCMP.1, pHBI59, p3C7, and pTHH26), MEN 2a (MCK2 and cTB14.34), basic fibroblast growth factor (pHFL1-7), (Ca2+,Mg2+)ATPase isoform 4 (hPMCA4), membrane Na/Ca exchanger (cNC28 M-A), PTH (pPTH-LF), and calbindin-D28K (pSKCalb).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP446481.RAl891B3Di4zrBVC_rBSW5lOE5KMcm348CTsS_aAHoZSY130_provenance.
- NP446481.RAl891B3Di4zrBVC_rBSW5lOE5KMcm348CTsS_aAHoZSY130_assertion evidence source_evidence_literature NP446481.RAl891B3Di4zrBVC_rBSW5lOE5KMcm348CTsS_aAHoZSY130_provenance.
- NP446481.RAl891B3Di4zrBVC_rBSW5lOE5KMcm348CTsS_aAHoZSY130_assertion SIO_000772 1517376 NP446481.RAl891B3Di4zrBVC_rBSW5lOE5KMcm348CTsS_aAHoZSY130_provenance.
- NP446481.RAl891B3Di4zrBVC_rBSW5lOE5KMcm348CTsS_aAHoZSY130_assertion wasDerivedFrom befree-2016 NP446481.RAl891B3Di4zrBVC_rBSW5lOE5KMcm348CTsS_aAHoZSY130_provenance.
- NP446481.RAl891B3Di4zrBVC_rBSW5lOE5KMcm348CTsS_aAHoZSY130_assertion wasGeneratedBy ECO_0000203 NP446481.RAl891B3Di4zrBVC_rBSW5lOE5KMcm348CTsS_aAHoZSY130_provenance.